HUE055414T2 - Eljárás aktivált hepatocita növekedési faktor (HGF) elõállítására - Google Patents
Eljárás aktivált hepatocita növekedési faktor (HGF) elõállításáraInfo
- Publication number
- HUE055414T2 HUE055414T2 HUE17766718A HUE17766718A HUE055414T2 HU E055414 T2 HUE055414 T2 HU E055414T2 HU E17766718 A HUE17766718 A HU E17766718A HU E17766718 A HUE17766718 A HU E17766718A HU E055414 T2 HUE055414 T2 HU E055414T2
- Authority
- HU
- Hungary
- Prior art keywords
- hgf
- growth factor
- hepatocyte growth
- producing activated
- activated hepatocyte
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21034—Plasma kallikrein (3.4.21.34)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21073—Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016054128 | 2016-03-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE055414T2 true HUE055414T2 (hu) | 2021-11-29 |
Family
ID=59850449
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE17766718A HUE055414T2 (hu) | 2016-03-17 | 2017-03-15 | Eljárás aktivált hepatocita növekedési faktor (HGF) elõállítására |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US11548926B2 (hu) |
| EP (1) | EP3431590B1 (hu) |
| JP (1) | JP6861201B2 (hu) |
| KR (1) | KR102275262B1 (hu) |
| CN (1) | CN109196099B (hu) |
| AU (1) | AU2017232582B2 (hu) |
| CA (1) | CA3014567C (hu) |
| DK (1) | DK3431590T3 (hu) |
| ES (1) | ES2894477T3 (hu) |
| HU (1) | HUE055414T2 (hu) |
| IL (1) | IL261066B (hu) |
| LT (1) | LT3431590T (hu) |
| MX (1) | MX2018010283A (hu) |
| RU (1) | RU2747977C2 (hu) |
| SG (1) | SG11201806843UA (hu) |
| WO (1) | WO2017159722A1 (hu) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11548926B2 (en) | 2016-03-17 | 2023-01-10 | Eisai R&D Management Co., Ltd. | Method for producing an active hepatocyte growth factor (HGF) |
| CN110607304A (zh) * | 2019-07-25 | 2019-12-24 | 广州凌腾生物医药有限公司 | 肝细胞生长因子的重组表达方法 |
| CN110606883A (zh) * | 2019-07-25 | 2019-12-24 | 广州凌腾生物医药有限公司 | 肝细胞生长因子的制备方法 |
| WO2024096038A1 (ja) * | 2022-11-01 | 2024-05-10 | クリングルファーマ株式会社 | 活性型ｈｇｆの製造方法 |
Family Cites Families (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2564486B2 (ja) | 1986-07-14 | 1996-12-18 | 修治 橋本 | 肝細胞増殖因子 |
| NZ232813A (en) | 1989-03-10 | 1992-08-26 | Snow Brand Milk Products Co Ltd | Human fibroblast glycoprotein, cell differentiation, blood vessel endothelial cell growth factor, cellular immunology inforcing factor of 78 or 74 thousand daltons plus or minus two thousand daltons |
| JP2706704B2 (ja) | 1989-06-05 | 1998-01-28 | 敏一 中村 | 組換ヒト肝実質細胞増殖因子 |
| JP3036782B2 (ja) | 1990-04-03 | 2000-04-24 | 三菱化学株式会社 | ヒト肝実質細胞増殖因子の生産方法および該因子を産生する形質転換体 |
| JP2577091B2 (ja) | 1989-08-11 | 1997-01-29 | 三菱化学株式会社 | 肝実質細胞増殖因子及びそれをコードする遺伝子 |
| JP2777678B2 (ja) | 1990-06-11 | 1998-07-23 | 敏一 中村 | 組換ヒト肝実質細胞増殖因子及びその製造方法 |
| JP3072628B2 (ja) | 1990-11-19 | 2000-07-31 | 敏一 中村 | ヒト肝実質細胞増殖因子をコードする染色体ｄｎａ |
| JP3213985B2 (ja) * | 1991-10-18 | 2001-10-02 | 三菱化学株式会社 | 新規なタンパク質 |
| JP3232714B2 (ja) * | 1992-11-20 | 2001-11-26 | 三菱化学株式会社 | 新規なタンパク質およびそれをコードする遺伝子 |
| CA2102463A1 (en) * | 1992-11-05 | 1994-05-06 | Mitsubishi Chemical Corporation | Protein and gene encoding said protein |
| NZ262634A (en) | 1993-02-23 | 1997-02-24 | Genentech Inc | Stabilizing polypeptides against degradation by organic solvents by admixing the peptide with trehalose or mannitol |
| JP2577091Y2 (ja) | 1993-06-23 | 1998-07-23 | 賢一 片山 | 分流装置の合成樹脂製サドル |
| JP3680114B2 (ja) * | 1993-09-17 | 2005-08-10 | 敏一 中村 | 脳神経障害治療剤 |
| JP2747979B2 (ja) | 1994-08-19 | 1998-05-06 | 雪印乳業株式会社 | ヒト由来の糖蛋白質からなる生理活性因子を有効成分とする医薬 |
| JP3927248B2 (ja) | 1995-07-11 | 2007-06-06 | 第一製薬株式会社 | Ｈｇｆ凍結乾燥製剤 |
| JP2859577B2 (ja) | 1996-03-27 | 1999-02-17 | 三菱化学株式会社 | 肝実質細胞増殖因子 |
| JP4463885B2 (ja) | 1996-12-05 | 2010-05-19 | 敏一 中村 | 劇症肝炎疾患治療剤 |
| JP2980888B2 (ja) | 1998-07-09 | 1999-11-22 | 三菱化学株式会社 | 肝実質細胞増殖因子をコードする遺伝子 |
| DE60034445T2 (de) | 1999-05-31 | 2008-01-03 | Mitsubishi Chemical Corp. | Gefriergetrocknete hgf-präparationen |
| JP3072628U (ja) | 2000-02-17 | 2000-10-24 | 輝夫 尾形 | ステンドグラス製文字入り記念楯 |
| JP4090236B2 (ja) * | 2000-12-05 | 2008-05-28 | 三菱化学株式会社 | 活性型肝細胞増殖因子アクティベーターに対する特異的抗体とその使用法 |
| US7045602B2 (en) * | 2000-12-05 | 2006-05-16 | Mitsubishi Chemical Corporation | Specific antibody directed to active hepatocyte growth factor activator and method for using the same |
| DE10204792A1 (de) | 2002-02-06 | 2003-08-14 | Merck Patent Gmbh | Lyophilisierte Zubereitung enthaltend Immuncytokine |
| US7432044B2 (en) * | 2004-07-26 | 2008-10-07 | Genentech, Inc. | Methods and compositions for modulating hepatocyte growth factor activation |
| WO2006063300A2 (en) * | 2004-12-10 | 2006-06-15 | Genentech, Inc. | Crystal structure of hepatocyte growth factor activator complexed with kunitz domain inhibitor |
| KR20080082629A (ko) * | 2005-11-10 | 2008-09-11 | 리셉터 바이오로직스 인크 | 간세포 성장인자 인트론 융합 단백질 |
| EP2014676B1 (en) | 2006-04-20 | 2012-03-07 | Kringle Pharma Inc. | Hgf precursor protein mutant and activated form thereof |
| CA2673260A1 (en) | 2006-12-20 | 2008-07-03 | Bayer Healthcare Llc | Factor vii and viia compositions |
| WO2008102452A1 (ja) | 2007-02-22 | 2008-08-28 | Kringle Pharma Inc. | Ｈｇｆ製剤 |
| US9393304B2 (en) | 2008-10-29 | 2016-07-19 | Ablynx N.V. | Formulations of single domain antigen binding molecules |
| CN101649320B (zh) * | 2009-09-15 | 2011-06-15 | 上海交通大学医学院附属仁济医院 | 重组人源hgf激活因子及其应用 |
| AR078667A1 (es) | 2009-10-19 | 2011-11-23 | Genentech Inc | Moduladores de activador del factor de crecimiento de hepatocitos (hgfa) |
| WO2011102845A1 (en) | 2010-02-18 | 2011-08-25 | Transtech Pharma, Inc. | Rage fusion protein compositions and methods of use |
| JP2012051822A (ja) | 2010-08-31 | 2012-03-15 | Institute Of Physical & Chemical Research | 肺癌診断用ポリペプチド、肺癌の検出方法、および治療効果の評価方法 |
| WO2012144535A1 (ja) | 2011-04-18 | 2012-10-26 | 国立大学法人京都大学 | 急性肝不全抑制剤及びその薬効評価法 |
| WO2013018851A1 (ja) | 2011-08-02 | 2013-02-07 | 独立行政法人国立がん研究センター | 誘導肝幹細胞から肝分化誘導する方法及び誘導肝前駆細胞 |
| EP2807189B1 (en) * | 2012-01-23 | 2019-03-20 | Ablynx N.V. | Sequences directed against hepatocyte growth factor (hgf) and polypeptides comprising the same for the treatment of cancers and/or tumors |
| WO2014063128A1 (en) | 2012-10-20 | 2014-04-24 | Board Of Regents, The University Of Texas System | Cancer cell trap |
| RU2506946C1 (ru) | 2012-11-28 | 2014-02-20 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Воронежская государственная медицинская академия им. Н.Н. Бурденко" Министерства здравоохранения и социального развития Российской Федерации | Технология лиофилизации обогащенной тромбоцитами плазмы с сохранением жизнеспособности факторов tgf pdgf vegf |
| MX2016013667A (es) | 2014-04-28 | 2017-01-23 | Eisai R&D Man Co Ltd | Formulacion liofilizada de factor de crecimiento hepatico (hgf). |
| US11548926B2 (en) | 2016-03-17 | 2023-01-10 | Eisai R&D Management Co., Ltd. | Method for producing an active hepatocyte growth factor (HGF) |
| WO2017159771A1 (ja) | 2016-03-18 | 2017-09-21 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 肝細胞増殖因子（ｈｇｆ）のｐｄマーカー |
| CN208371461U (zh) | 2017-08-21 | 2019-01-15 | 潍坊鸿旺工贸有限公司 | 一种晾衣架用连接构件及晾衣架 |
-
2017
- 2017-03-15 US US16/078,568 patent/US11548926B2/en active Active
- 2017-03-15 SG SG11201806843UA patent/SG11201806843UA/en unknown
- 2017-03-15 DK DK17766718.5T patent/DK3431590T3/da active
- 2017-03-15 AU AU2017232582A patent/AU2017232582B2/en active Active
- 2017-03-15 KR KR1020187024470A patent/KR102275262B1/ko active IP Right Grant
- 2017-03-15 JP JP2018505972A patent/JP6861201B2/ja active Active
- 2017-03-15 MX MX2018010283A patent/MX2018010283A/es unknown
- 2017-03-15 LT LTEPPCT/JP2017/010355T patent/LT3431590T/lt unknown
- 2017-03-15 RU RU2018130530A patent/RU2747977C2/ru active
- 2017-03-15 HU HUE17766718A patent/HUE055414T2/hu unknown
- 2017-03-15 CA CA3014567A patent/CA3014567C/en active Active
- 2017-03-15 EP EP17766718.5A patent/EP3431590B1/en active Active
- 2017-03-15 WO PCT/JP2017/010355 patent/WO2017159722A1/ja active Application Filing
- 2017-03-15 CN CN201780013057.7A patent/CN109196099B/zh active Active
- 2017-03-15 ES ES17766718T patent/ES2894477T3/es active Active
-
2018
- 2018-08-08 IL IL261066A patent/IL261066B/en unknown
-
2022
- 2022-05-05 US US17/737,343 patent/US20220267393A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN109196099B (zh) | 2022-01-11 |
| IL261066B (en) | 2021-08-31 |
| AU2017232582A1 (en) | 2018-08-30 |
| US20190062390A1 (en) | 2019-02-28 |
| LT3431590T (lt) | 2021-09-10 |
| EP3431590A4 (en) | 2019-11-20 |
| ES2894477T3 (es) | 2022-02-14 |
| RU2018130530A3 (hu) | 2020-08-13 |
| EP3431590A1 (en) | 2019-01-23 |
| JPWO2017159722A1 (ja) | 2019-01-24 |
| CA3014567C (en) | 2024-02-20 |
| JP6861201B2 (ja) | 2021-04-21 |
| AU2017232582B2 (en) | 2022-07-14 |
| EP3431590B1 (en) | 2021-07-28 |
| CA3014567A1 (en) | 2017-09-21 |
| MX2018010283A (es) | 2019-01-31 |
| CN109196099A (zh) | 2019-01-11 |
| KR20180127322A (ko) | 2018-11-28 |
| KR102275262B1 (ko) | 2021-07-12 |
| WO2017159722A1 (ja) | 2017-09-21 |
| SG11201806843UA (en) | 2018-09-27 |
| US20220267393A1 (en) | 2022-08-25 |
| US11548926B2 (en) | 2023-01-10 |
| IL261066A (en) | 2018-10-31 |
| RU2018130530A (ru) | 2020-04-17 |
| RU2747977C2 (ru) | 2021-05-18 |
| DK3431590T3 (da) | 2021-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL258481B (en) | A method for extracorporeal health support | |
| EP3291264C0 (en) | METHOD FOR PRODUCING A SINTERED R-IRON-BORON MAGNET | |
| EP3333266A4 (en) | PROCESS FOR THE PRODUCTION OF SELENOEINE | |
| IL266044B (en) | Method for the production of 3-alkylsulfanyl-2-chloro-n-(1-alkyl-h1-tetrazol-5-yl)-4-trifluoromethyl-benzamides | |
| EP3395530A4 (en) | PROCESS FOR THE PRODUCTION OF STRUCTURE | |
| IL261066B (en) | A method for producing activated hepatocyte growth factor (hgf). | |
| EP3296282A4 (en) | METHOD FOR PRODUCING HYDROHALOGEN FLUOROLEFINES | |
| IL252173A0 (en) | Methods for the production of methyl dichlorophosphane | |
| HUE053428T2 (hu) | Eljárás otikus progenitorok elõállítására | |
| EP3275886A4 (en) | Method for producing dialkylaminosilane | |
| SG11201701326YA (en) | Method for producing oligosilane | |
| HK1249098A1 (zh) | 用於生產氟美他酚的方法 | |
| HK1256031A1 (zh) | 新的4-苯並偶氮寧衍生物的製造方法 | |
| EP3387175A4 (en) | PROCESS FOR FORMING POROUS FIBERS | |
| EP3248958A4 (en) | Method for producing fluoropropene | |
| IL255093A0 (en) | A method for the production of levoglucosenon | |
| SG11201907182QA (en) | Method for producing perfluoroalkadiene compounds | |
| IL254934B (en) | A method for the production of acylsulfamoylbenzamides | |
| PL3508512T3 (pl) | Sposób wytwarzania poliwęglanu | |
| PL3511315T3 (pl) | Sposób wytwarzania n-metylo-para-anizydyny | |
| SG11201802495UA (en) | Method for producing l-methionine | |
| SG11201802624YA (en) | Method for producing l-methionine | |
| PL3299394T3 (pl) | Sposób wytwarzania zmodyfikowanych ksylopolisacharydów | |
| ZA201903463B (en) | Method for preparing hexadecahydropyrene | |
| SG11202003954QA (en) | Method for producing dihydroxyindoles |